Pozis Family
Found 5 recent publications
Novolog reports mark end of an era: slight revenue growth, low profitability amid financing costs
Novolog released its Q2 2026 results following a management overhaul and the consolidation of the Pozis family's control. Net profit dropped to 541,000 shekels from 4.6 million shekels in the same quarter last year, driven by higher financing expenses.
60-year-old company in crisis: founder's grandson wins power struggle and ousts the board
The short power struggle at the medical services company Novolog has turned the spotlight on the battered stock, which lost 76% of its value at its peak, and on the successful entrepreneur who brought it to the stock exchange but prefers to operate under the radar. What went wrong in Novolog's success story, and can it get back on the path to success after the Pozis family's renewed takeover and...
Pozis Family Increases Stake in Novolog Amid Control Struggle
The Pozis family is acquiring an 18.2% stake in Novolog from Phoenix and Arkin at a 19% premium. The move comes as a counter-measure to Eli Dahan's attempt to invest 100 million shekels, which would have diluted the founding family's holdings.
“Improper Conspiracy” and “Poison Pill”: The Battle for Control of Novolog
The Pozis family, controlling shareholders of Novolog, has accused the board of directors of attempting to entrench power through a 100 million shekel investment deal with the Movement group, sparking a corporate power struggle.
The Pozis family on the control of Novolog: "We will fight legally and if necessary we will increase our holdings"
The Pozis family, controlling shareholders of Novolog, announced plans to replace the board of directors. This move triggered a power struggle and a 16.6% surge in the company's share price.